Timothy Sullivan - Apr 19, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Financial Officer
Signature
/s/ David Watson, attorney-in-fact for Timothy Sullivan
Stock symbol
APLS
Transactions as of
Apr 19, 2023
Transactions value $
$0
Form type
4
Date filed
4/20/2023, 04:15 PM
Previous filing
Feb 22, 2023
Next filing
May 3, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Gift $0 -36.2K -27.05% $0.00 97.7K Apr 19, 2023 Direct
transaction APLS Common Stock Gift $0 +36.2K $0.00 36.2K Apr 19, 2023 Indirect Owner (The Timothy E Sullivan Irrevocable Trust of 2023) F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 19, 2023, the reporting person transferred 36,232 shares to The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.